- Home
- FLEX vs BNTX Comparison
FLEX vs BNTX Comparison
Compare FLEX & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLEX | BNTX |
|---|---|---|
| Founded | 1990 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3B | 22.8B |
| IPO Year | 1997 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FLEX | BNTX |
|---|---|---|
| Price | $66.24 | $86.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | $61.11 | ★ $134.15 |
| AVG Volume (30 Days) | ★ 2.9M | 1.3M |
| Earning Date | 05-06-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $28,679,925,000.00 | N/A |
| Revenue This Year | $8.11 | N/A |
| Revenue Next Year | $6.28 | $4.76 |
| P/E Ratio | $37.15 | ★ N/A |
| Revenue Growth | ★ 18.95 | N/A |
| 52 Week Low | $25.11 | $79.81 |
| 52 Week High | $72.22 | $124.00 |
Technical Indicators
Market Signals| Indicator | FLEX | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 33.89 |
| Support Level | $54.79 | $79.81 |
| Resistance Level | $66.93 | $113.12 |
| Average True Range (ATR) | 2.75 | 3.04 |
| MACD | 0.26 | -0.66 |
| Stochastic Oscillator | 96.94 | 29.22 |
Price Performance
Historical ComparisonAbout FLEX Flex Ltd.
Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.